I Kausch von Schmeling

Summary

Country: Germany

Publications

  1. ncbi request reprint Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer
    Ingo Kausch
    Department of Urology, University of Lubeck Medical School, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Expert Rev Anticancer Ther 6:1301-11. 2006
  2. doi request reprint [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis]
    I Kausch
    Klinik für Urologie, Universitat zu Lubeck, Universitatsklinikum Schleswig Holstein, Campus Lubeck, Lubeck, Deutschland
    Aktuelle Urol 41:171-7. 2010
  3. doi request reprint [Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art]
    I Kausch von Schmeling
    Klinik für Urologie, Universitat zu Lubeck, UK S H, Lubeck
    Aktuelle Urol 41:307-15. 2010
  4. doi request reprint Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies
    Ingo Kausch
    Department of Urology, University at Lubeck, University Hospital Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Eur Urol 57:595-606. 2010
  5. doi request reprint [Endourological lithotripsy for stone removal: accidental fragmentation of dormia basket and guidewire - a brief overview]
    J Cordes
    Klinik für Urologie, Campus Lubeck, Universitatsklinikum Schleswig Holstein, Ratzeburger Allee 160, 23538 Lubeck, Deutschland
    Urologe A 49:1365-7. 2010
  6. doi request reprint [Squamous cell carcinoma of the renal pelvis. Therapeutic options for a rare entity]
    B Kazarians
    Klinik und Poliklinik fur Urologie, Universitatsklinikum Schleswig Holstein, Campus Lubeck
    Aktuelle Urol 39:456-8. 2008
  7. ncbi request reprint In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer
    Caroline E Blietz
    Department of Urology, University of Lubeck, Lubeck, Germany
    In Vivo 23:13-9. 2009
  8. ncbi request reprint Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma
    Stefan Kruger
    Department of Pathology, University of Schleswig Holstein, Lubeck, Germany
    Urology 67:105-9. 2006
  9. ncbi request reprint Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma
    Stefan Kruger
    Institute of Pathology, University of Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Oncology 68:269-75. 2005
  10. ncbi request reprint Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications
    Stefan Kruger
    Institute of Pathology, University of Schleswig Holstein, Lubeck, Germany
    Anticancer Res 25:263-71. 2005

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer
    Ingo Kausch
    Department of Urology, University of Lubeck Medical School, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Expert Rev Anticancer Ther 6:1301-11. 2006
    ..Additional approaches, such as photodynamic therapy with different photosensitizers and thermotherapy in combination with intravesical chemotherapy, have been evaluated in Phase III studies...
  2. doi request reprint [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis]
    I Kausch
    Klinik für Urologie, Universitat zu Lubeck, Universitatsklinikum Schleswig Holstein, Campus Lubeck, Lubeck, Deutschland
    Aktuelle Urol 41:171-7. 2010
    ..Heterogeneous results of single studies with photodynamic diagnosis (PDD) in bladder cancer have been reported. A metaanalysis of prospective studies has now been performed...
  3. doi request reprint [Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art]
    I Kausch von Schmeling
    Klinik für Urologie, Universitat zu Lubeck, UK S H, Lubeck
    Aktuelle Urol 41:307-15. 2010
    ..The question as to what has to be done in failure after BCG is discussed. Cystectomy is a safe option but other approaches are potential alternatives...
  4. doi request reprint Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies
    Ingo Kausch
    Department of Urology, University at Lubeck, University Hospital Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Eur Urol 57:595-606. 2010
    ..The clinical benefit of photodynamic diagnosis (PDD) with 5-aminolevulinic acid or hexaminolevulinate in addition to white-light cystoscopy (WLC) in bladder cancer has been discussed controversially...
  5. doi request reprint [Endourological lithotripsy for stone removal: accidental fragmentation of dormia basket and guidewire - a brief overview]
    J Cordes
    Klinik für Urologie, Campus Lubeck, Universitatsklinikum Schleswig Holstein, Ratzeburger Allee 160, 23538 Lubeck, Deutschland
    Urologe A 49:1365-7. 2010
    ..In this article we describe the energy needed for destroying specific foreign bodies and what currently and in the future will be the best way to avoid this problem...
  6. doi request reprint [Squamous cell carcinoma of the renal pelvis. Therapeutic options for a rare entity]
    B Kazarians
    Klinik und Poliklinik fur Urologie, Universitatsklinikum Schleswig Holstein, Campus Lubeck
    Aktuelle Urol 39:456-8. 2008
    ..The patient with SCC described here showed an above-average survival of 18 months after adjuvant radiochemotherapy. Treatment was initiated according to the guidelines for squamous cell carcinoma in non-urological localisations...
  7. ncbi request reprint In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer
    Caroline E Blietz
    Department of Urology, University of Lubeck, Lubeck, Germany
    In Vivo 23:13-9. 2009
    ..In search of new agents, antisense oligonucleotides (AS-ON) may be interesting candidates. The availability and toxicity as well as the effectivity of AS-ON after intravesical instillation in different rodent models were examined...
  8. ncbi request reprint Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma
    Stefan Kruger
    Department of Pathology, University of Schleswig Holstein, Lubeck, Germany
    Urology 67:105-9. 2006
    ..To determine whether clusterin immunoreactivity of muscle-invasive bladder carcinoma can predict disease-related survival of patients treated by radical cystectomy...
  9. ncbi request reprint Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma
    Stefan Kruger
    Institute of Pathology, University of Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Oncology 68:269-75. 2005
    ..Our aim was to analyze KIT expression immunohistochemically in renal cell carcinomas (RCCs) and in oncocytomas...
  10. ncbi request reprint Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications
    Stefan Kruger
    Institute of Pathology, University of Schleswig Holstein, Lubeck, Germany
    Anticancer Res 25:263-71. 2005
    ..Due to their variable clinical course, there is a need for new prognostic parameters in minimally invasive (stage T1) bladder carcinomas...
  11. ncbi request reprint Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancer
    Merle Hanke
    Kompetenzzentrum fuer Drug Design und Target Monitoring, Luebeck, Germany
    Clin Chem 53:2070-7. 2007
    ..We aimed to develop a procedure for measurement of tumor RNA in urine that would minimize donor-dependent influences on the results...